Cargando…
ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies
OBJECTIVE: Lupus pleuritis is the most common pulmonary manifestation of systemic lupus erythematosus (SLE). We aimed to compare various biomarkers in discriminating between pleural effusions due to lupus pleuritis and other aetiologies. METHODS: We determined in 59 patients (16 patients with SLE an...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596033/ https://www.ncbi.nlm.nih.gov/pubmed/34785570 http://dx.doi.org/10.1136/lupus-2021-000562 |
_version_ | 1784600274415910912 |
---|---|
author | Chen, Der-Yuan Huang, Yen-Hsiang Chen, Yi-Ming Chen, Jeremy J W Yang, Tsung-Ying Chang, Gee-Chen Tang, Kuo-Tung |
author_facet | Chen, Der-Yuan Huang, Yen-Hsiang Chen, Yi-Ming Chen, Jeremy J W Yang, Tsung-Ying Chang, Gee-Chen Tang, Kuo-Tung |
author_sort | Chen, Der-Yuan |
collection | PubMed |
description | OBJECTIVE: Lupus pleuritis is the most common pulmonary manifestation of systemic lupus erythematosus (SLE). We aimed to compare various biomarkers in discriminating between pleural effusions due to lupus pleuritis and other aetiologies. METHODS: We determined in 59 patients (16 patients with SLE and 43 patients without SLE) pleural fluid levels of high-mobility group box 1, soluble receptor for advanced glycation end products (sRAGE), adenosine deaminase (ADA), interleukin (IL) 17A, tumour necrosis factor-α, antinuclear antibodies (ANA), and complements C3 and C4. RESULTS: We found significant differences in the pleural fluid level of sRAGE, ADA, IL-17A, C3 and C4, and in the proportion of ANA positivity, among lupus pleuritis and other groups with pleural effusion. Specifically, ANA positivity (titre ≥1: 80) achieved a high sensitivity of 91%, specificity of 83% and negative predictive value (NPV) of 97% in discriminating lupus pleuritis from non-lupus pleural effusion. A parallel combination of the level of C3 (<24 mg/dL) and C4 (<3 mg/dL) achieved a sensitivity of 82%, specificity of 89% and NPV of 93% in discriminating lupus pleuritis from non-lupus exudative pleural effusion. CONCLUSIONS: In conclusion, ANA, C3 and C4 in pleural fluid are useful in discriminating lupus pleuritis from pleural effusion due to other aetiologies with high NPV. |
format | Online Article Text |
id | pubmed-8596033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-85960332021-11-24 ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies Chen, Der-Yuan Huang, Yen-Hsiang Chen, Yi-Ming Chen, Jeremy J W Yang, Tsung-Ying Chang, Gee-Chen Tang, Kuo-Tung Lupus Sci Med Biomarker Studies OBJECTIVE: Lupus pleuritis is the most common pulmonary manifestation of systemic lupus erythematosus (SLE). We aimed to compare various biomarkers in discriminating between pleural effusions due to lupus pleuritis and other aetiologies. METHODS: We determined in 59 patients (16 patients with SLE and 43 patients without SLE) pleural fluid levels of high-mobility group box 1, soluble receptor for advanced glycation end products (sRAGE), adenosine deaminase (ADA), interleukin (IL) 17A, tumour necrosis factor-α, antinuclear antibodies (ANA), and complements C3 and C4. RESULTS: We found significant differences in the pleural fluid level of sRAGE, ADA, IL-17A, C3 and C4, and in the proportion of ANA positivity, among lupus pleuritis and other groups with pleural effusion. Specifically, ANA positivity (titre ≥1: 80) achieved a high sensitivity of 91%, specificity of 83% and negative predictive value (NPV) of 97% in discriminating lupus pleuritis from non-lupus pleural effusion. A parallel combination of the level of C3 (<24 mg/dL) and C4 (<3 mg/dL) achieved a sensitivity of 82%, specificity of 89% and NPV of 93% in discriminating lupus pleuritis from non-lupus exudative pleural effusion. CONCLUSIONS: In conclusion, ANA, C3 and C4 in pleural fluid are useful in discriminating lupus pleuritis from pleural effusion due to other aetiologies with high NPV. BMJ Publishing Group 2021-11-15 /pmc/articles/PMC8596033/ /pubmed/34785570 http://dx.doi.org/10.1136/lupus-2021-000562 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Biomarker Studies Chen, Der-Yuan Huang, Yen-Hsiang Chen, Yi-Ming Chen, Jeremy J W Yang, Tsung-Ying Chang, Gee-Chen Tang, Kuo-Tung ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies |
title | ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies |
title_full | ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies |
title_fullStr | ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies |
title_full_unstemmed | ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies |
title_short | ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies |
title_sort | ana positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies |
topic | Biomarker Studies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596033/ https://www.ncbi.nlm.nih.gov/pubmed/34785570 http://dx.doi.org/10.1136/lupus-2021-000562 |
work_keys_str_mv | AT chenderyuan anapositivityandcomplementlevelinpleuralfluidarepotentialdiagnosticmarkersindiscriminatinglupuspleuritisfrompleuraleffusionofotheraetiologies AT huangyenhsiang anapositivityandcomplementlevelinpleuralfluidarepotentialdiagnosticmarkersindiscriminatinglupuspleuritisfrompleuraleffusionofotheraetiologies AT chenyiming anapositivityandcomplementlevelinpleuralfluidarepotentialdiagnosticmarkersindiscriminatinglupuspleuritisfrompleuraleffusionofotheraetiologies AT chenjeremyjw anapositivityandcomplementlevelinpleuralfluidarepotentialdiagnosticmarkersindiscriminatinglupuspleuritisfrompleuraleffusionofotheraetiologies AT yangtsungying anapositivityandcomplementlevelinpleuralfluidarepotentialdiagnosticmarkersindiscriminatinglupuspleuritisfrompleuraleffusionofotheraetiologies AT changgeechen anapositivityandcomplementlevelinpleuralfluidarepotentialdiagnosticmarkersindiscriminatinglupuspleuritisfrompleuraleffusionofotheraetiologies AT tangkuotung anapositivityandcomplementlevelinpleuralfluidarepotentialdiagnosticmarkersindiscriminatinglupuspleuritisfrompleuraleffusionofotheraetiologies |